Ranolazine

CAS 95635-55-5 24 current records 4 historicalSmall Molecule

Who holds supplier records for Ranolazine? 24 organisations hold a current record for Ranolazine: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (18), Spain (2), China (2) and Italy (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ranolazine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ranolazine

Reading the evidence

  • 24 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    18 of the 23 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (24)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ranolazine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India18Spain2China2Italy1Country not recorded for 1
Need Ranolazine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (4)

Organisations whose Type II DMFs for Ranolazine are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • Apotex Pharmachem India Pvt. Ltd.
    India · Inactive DMF 30712 · filed Aug 2016
  • India · Inactive DMF 23432 · filed Jan 2010
  • India · Inactive DMF 23245 · filed Dec 2009
  • India · Inactive DMF 21966 · filed Dec 2008

Overview

Ranolazine is an anti-anginal medication that works by improving blood flow to help the heart work more efficiently. It has been shown to improve exercise tolerance and reduce the frequency of angina attacks.

Chemical identity

IUPAC name
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
Canonical SMILES
CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
InChIKey
XKLMZUWKNUAPSZ-UHFFFAOYSA-N
Synonyms
Ranexa API, aspruzyo, cvt-303, nsc-759100, ran d, ran4, ranexa, rs-43285-003

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anti-anginal
Mechanism of action
Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A Inhibitors; Organic Cation Transporter 2 Inhibitors; P-Glycoprotein Inhibitors

Therapeutic areas

Cardiovascular diseasesAngina

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ranolazine?

24 organisations hold an active US FDA Type II Drug Master File or a CEP for Ranolazine: AARTI PHARMALABS LIMITED (India), Ajanta Pharma Limited (India), ALIVUS LIFE SCIENCES LTD (India), ALMELO PRIVATE LTD (India), AMOLI ORGANICS PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), CHEMO SMS ENTERPRISE SL (Spain) and COSMA SPA (Italy), and 16 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ranolazine Drug Master Files are active?

AARTI PHARMALABS LIMITED (DMF 21866), Ajanta Pharma Limited (DMF 37993), ALIVUS LIFE SCIENCES LTD (DMF 32573), ALMELO PRIVATE LTD (DMF 33030), AMOLI ORGANICS PRIVATE LTD (DMF 33001), APITORIA PHARMA PRIVATE LTD (DMF 29483), CHEMO SMS ENTERPRISE SL (DMF 32133) and COSMA SPA (DMF 22811) and 16 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ranolazine records mean?

4 organisations have only inactive Type II DMFs for Ranolazine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Ranolazine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ranolazine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.